Literature DB >> 12639877

Obstacles to the initiation of beta blockers for heart failure in a specialised clinic within a district general hospital.

M Mahmoudi, S McDonagh, Pa Poole-Wilson, S W Dubrey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12639877      PMCID： PMC1769262          DOI： 10.1136/heart.89.4.442

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.

Authors:  P Lechat; M Packer; S Chalon; M Cucherat; T Arab; J P Boissel
Journal:  Circulation       Date:  1998-09-22       Impact factor: 29.690

2.  Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidémiologie de l'Insuffisance Cardiaque Avancée en Lorraine.

Authors:  F Zannad; S Briancon; Y Juilliere; P M Mertes; J P Villemot; F Alla; J M Virion
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

3.  Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.

Authors:  E Erdmann; P Lechat; P Verkenne; H Wiemann
Journal:  Eur J Heart Fail       Date:  2001-08       Impact factor: 15.534

4.  Baseline predictors of tolerability to carvedilol in patients with chronic heart failure.

Authors:  H Krum; D Ninio; P MacDonald
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

5.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

Authors: 
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321
  5 in total
  2 in total

1.  Effect of a community heart failure clinic on uptake of beta blockers by patients with obstructive airways disease and heart failure.

Authors:  R J Shelton; A S Rigby; J G F Cleland; A L Clark
Journal:  Heart       Date:  2005-06-10       Impact factor: 5.994

2.  Bisoprolol protects myocardium cells against ischemia/reperfusion injury by attenuating unfolded protein response in rats.

Authors:  Chengcheng Zhang; Songqing He; Yanming Li; Feng Li; Zhengbing Liu; Jing Liu; Jianbin Gong
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.